Chronic Pain Standard Proposed By FDA Too Strict, Four Trials OK, Cmte Says
Executive Summary
Global chronic pain can be an appropriate Rx analgesic indication, but the revised clinical trial requirements under consideration by FDA may be too stringent, Arthritis Advisory Committee members said